glp 1 glucagon dual receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Pemvidutide vs Survodutide: GLP-1/Glucagon Dual

Description

90% of patients achieved more than 5% weight loss compared to 24% on placebo

At this point, domperidone should be preferred over metoclopramide due to the risk of extrapyramidal side effects

Actual phrases, preparation checklists, documentation strategies, and step-by-step scripts that help you walk into that appointment feeling informed and ready to have a productive conversation about your health

Garvey WT, Batterham RL, Bhatta M, et al

This article gives an overview on the characteristics of the various DPP-4 inhibitors in clinical use and highlights the positioning of the drug class in the guidelines for the treatment of type 2 diabetes